These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3282729)

  • 1. Short-term treatment with captopril in hypertension due to acute glomerulonephritis.
    Parra G; Rodríguez-Iturbe B; Colina-Chourio J; García R
    Clin Nephrol; 1988 Feb; 29(2):58-62. PubMed ID: 3282729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Captopril in the treatment of arterial hypertension in chronic nephritis].
    Kutyrina IM; Rogov VA; Lifshits NL; Klepikov PV
    Ter Arkh; 1986; 58(8):92-6. PubMed ID: 3532416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing effects of two angiotensin converting enzyme inhibitors, captopril and CI-906, on diuresis and the urinary excretion of kallikrein and prostaglandins in spontaneously hypertensive rats.
    Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Laitinen LA; Manninen V; Ylitalo P; Vapaatalo H
    Scand J Urol Nephrol Suppl; 1984; 79():23-7. PubMed ID: 6089314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
    Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
    J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of prostaglandins (PGE2 and PGF2 alpha) and kallikrein in acute glomerulonephritis.
    Colina-Chourio JA; Rodríguez-Iturbe B; Baggio B; García R; Borsatti A
    Clin Nephrol; 1983 Nov; 20(5):217-24. PubMed ID: 6580982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.
    Zacharieva S; Torbova S; Orbetzova M; Borissova AM; Andonova K; Sheitanova S
    Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):205-9. PubMed ID: 8738072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
    Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
    Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension.
    Rasmussen S; Ibsen H; Giese J
    Scand J Urol Nephrol Suppl; 1984; 79():49-52. PubMed ID: 6089319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
    Uhlenius N; Vuolteenaho O; Tikkanen I
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of antihypertensive effect of atenolol in patients with borderline hypertension during short-term treatment. A comprehensive study.
    Imai Y; Abe K; Sato M; Kasai Y; Sato K; Omata K; Sasaki S; Nihei M; Sekino H; Yoshinaga K
    Arzneimittelforschung; 1986 May; 36(5):869-73. PubMed ID: 3730023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of captopril on the urinary excretion of prostanoids and kallikrein in spontaneously hypertensive rats.
    Säynävälammi P
    Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):285-90. PubMed ID: 3541494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes of components in the kinin system and plasma renin activity during different stages of hypertension in patients treated with captopril].
    Kolber-Postepska B; Zebrowska-Lupina I; Markiewicz M; Horubała-Bielak G
    Pol Tyg Lek; 1994 Mar 7-14; 49(10-11):245-8. PubMed ID: 7862589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of prostaglandin in the antihypertensive mechanism of captopril in low renin hypertension.
    Abe K; Ito T; Sato M; Haruyama T; Sato K; Omata K; Hiwatari M; Sakurai Y; Imai Y; Yoshinaga K
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():141s-144s. PubMed ID: 7004721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition.
    Johnston CI; Clappison B; McGrath BP; Matthews PG; Millar JA; Anderson WP
    Prog Biochem Pharmacol; 1980; 17():123-33. PubMed ID: 6259649
    [No Abstract]   [Full Text] [Related]  

  • 20. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats.
    Kohzuki M; Yasujima M; Kanazawa M; Yoshida K; Fu LP; Obara K; Saito T; Abe K
    J Hypertens; 1995 Jan; 13(1):97-103. PubMed ID: 7759858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.